In addition to scientific sessions, Day 3 of ISAM 2013 included awards presentations and the organization’s general assembly meeting. During the awards ceremony, Bill Bennett presented the Jurai Ferin award to Patrice Diot of the University Hospital of Tours, France. Along with the certificate of recognition, Diot received the gift of a balloon trip over . . . Read more
The first session of Day 2 of the 2013 ISAM Congress concerned “Aerosol Deposition at the Extremes: . . . Read more
On the first full day of the International Society of Aerosol Medicine (ISAM) 2013 Congress, Congress Chair Bill Bennett welcomed approximately 330 delegates to the University of North Carolina, Chapel Hill. Many of the delegates had already attended ISAM events on Saturday, including three pre-Congress workshops and a welcome reception. More than 50 people attended . . . Read more
Delegates to RDD Europe 2013, which will take place May 21-24, will notice familiar features from past iterations of the event alongside several innovations designed to enhance the meeting experience. . . . Read more
Grifols is paying $25 million upfront, plus up to $25 million in milestone payments to acquire a worldwide license for Aradigm’s Pulmaquin and Lipoquin inhaled ciprofloxacin formulations. Grifols will also pay tiered royalties on worldwide sales of products using the formulations and will be responsible for up to $65 million in expenses for Phase 3 . . . Read more
Malvern Instruments has announced that it will team up with Proveris Scientific Corporation on a nasal spray characterization system called Solo for Spraytec, which combines Proveris’s automated actuator and software for precise control of device actuation with Malvern’s Spraytec laser diffraction particle size analyzer. The FDA recommends laser diffraction for bioavailability/bioequivalence studies for nasal sprays, . . . Read more
Inhaled drug developer Vectura has announced better than expected preliminary results for the year ending March 31, 2013, with the company’s loss before tax 21% lower than in 2011/12. The company also announced that Paul Oliver will replace Anne Hyland as CFO. Vectura CEO Chris Blackwell said, “The past year has been very significant for . . . Read more